How to Buy Cidara Therapeutics Stock
Cidara Therapeutics Inc
Cidara Therapeutics, Inc. , a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States.
Cidara Therapeutics stock last closed at $0.68, down 5.68% from the previous day, and has decreased 39.2% in one year. It has underperformed other stocks in the Biotechnology industry by 0.14 percentage points. Cidara Therapeutics stock is currently +14.84% from its 52-week low of $0.59, and -53.99% from its 52-week high of $1.48.
At the moment, there are 90.43M CDTX shares outstanding. The market capitalization of CDTX is $61.59M. In the past 24 hours, 352,272 CDTX shares were traded.
How to Buy Cidara Therapeutics Stock
Not sure how to invest in Cidara Therapeutics stock? Here's how.
- Decide where to buy Cidara Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you choose where to buy Cidara Therapeutics stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Choose your method of payment and add your information.
- Analyze Cidara Therapeutics stock: The Cidara Therapeutics ticker symbol is CDTX. Is Cidara Therapeutics stock a good investment? Should you buy shares of CDTX? How do CDTX's underlying business fundamentals look? Do top analysts think Cidara Therapeutics is a good buy? Why has CDTX's stock price moved recently? (Hint: Our stock research tools can help you evaluate if CDTX is a good stock to buy).
- Execute your CDTX buy order: Decide if you will purchase CDTX shares at the current market price or use a limit order to buy CDTX shares at a given price.
- Watch your investment in CDTX: Create a watchlist to important updates regarding your investment in Cidara Therapeutics stock.
Step 1: Decide where to buy Cidara Therapeutics stock
You will need a brokerage account to access the NASDAQ market and buy CDTX stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Utilities, New York to London — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked the best brokerage, the next step is to fill out some personal info so you can invest in CDTX stock today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to start a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have created your account on app for investing, you can securely and quickly fund your account:
Check out this video walkthrough if you need help depositing funds into your brokerage account.
Step 4: Analyze Cidara Therapeutics stock
After you have chosen the best place to buy Cidara Therapeutics stock, it's absolutely critical to research their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
Cidara Therapeutics shares data
CDTX Zen Score
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in less time.
You can view all of the due diligence checks on CDTX's stock page.
How is CDTX stock valued?
You can use many financial metrics, analyses, models, and charts to gauge CDTX's intrinsic value.
Using relative valuations measures:
- CDTX could be overvalued based on its P/B ratio of 7.66x, relative to Biotechnology industry P/B ratio of 5.74x
You can access more valuation research on CDTX's stock here.
CDTX Financial Health
Signs that CDTX is financially healthy:
- There are more short-term assets than long-term liabilities on the CDTX balance sheet.
- CDTX has $48.67M in cash and short term investments. This is sufficient to cover its annual cash burn of $31.05M.
- There are more short-term assets than short-term liabilities on the CDTX balance sheet.
- CDTX has cash burn of 31048000. It has sufficient cash and short-term investments to cover this for at least one year.
Signs that CDTX is not financially healthy:
- CDTX profit margin has gone up by 0.04 percentage points in the past year, but the company is still unprofitable.
- Total CDTX debt is higher than 5 years ago, relative to shareholder equity.
- CDTX has a relatively high debt to equity ratio of 6.9.
Is it a good time to buy Cidara Therapeutics stock, according to Wall Street analysts?
Out of 1 Equities analysts who give recommendations on CDTX, the consensus analyst rating on Cidara Therapeutics is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are forecasting on the Cidara Therapeutics stock forecast page.
CDTX Technicals
CDTX Performance Metrics
Last year, CDTX revenue was $56.54M. During the last four year, CDTX's revenue has increased by 31.17% per year. This was faster than the Biotechnology industry average of 28.92%.
Dive into CDTX's earnings and revenue performance here.
What are CDTX insiders up to?
In the last 12 months, executives and large shareholders at CDTX have sold more shares than they have bought.
Taylor Sandison, Chief Medical Officer of CDTX, was the latest CDTX insider to sell. They sold $13,843.54 worth of CDTX shares on Mar 11, 2024.
Get more info about who owns CDTX stock here.
Does CDTX provide a stable income stream?
No, Cidara Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about CDTX
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your CDTX buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, use a limit order.
Hit the Open button and your broker will place the order.
If you require additional help investing in stocks on eToro, click the helpful video below:
Step 6: Watch your investment in CDTX
Now that you own some CDTX stock, you'll want to keep up with your new investment.
Start a watchlist to track your CDTX stock.
CDTX Feed
How to Buy Stock in Cidara Therapeutics
To summarize, here are the 6 steps to buy stock in Cidara Therapeutics:
- Decide where to buy Cidara Therapeutics stock
- Open your brokerage account
- Fund your brokerage account
- Analyze Cidara Therapeutics stock
- Execute your CDTX buy order
- Watch your investment in CDTX
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep track of your investment in Cidara Therapeutics, create your watchlist below.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.